Klin Farmakol Farm. 2009;23(4):162-165

Neuropsychiatric manifestations in digoxin intoxication

Štefan Alušík, Zoltán Paluch, Magdalena Lejsková, Věra Jedličková, Tomáš Adámek
1 . interní klinika Fakultní Thomayerovy nemocnice a Institutu postgraduálního vzdělávání ve zdravotnictví, Praha

Aim of study: The aim of the study was to determine the incidence of neuropsychiatric changes in a group of patients hospitalized with

pathological plasma digoxin levels and to correlate these changes with other manifestations of digitalis intoxication.

Method: We analyzed clinical and laboratory data including drug therapy data obtained from the medical records of patients hospitalized

over the last 36 months.

Results: Plasma digoxin levels above 2 ng/ml were seen in 171 patients, clinical manifestations of intoxication were demonstrated in

106 patients, and present in all patients with plasma levels above 3 ng/ml. Neuropsychiatric manifestations were noted in 15 % of all

patients.

Conclusions: Neuropsychiatric manifestations are not specific, and they may be difficult to diagnose, especially in elderly patients. Their

lower incidence in our group of patients is due to the retrospective nature of our analysis. Risk factors of intoxication included very old

age and renal dysfunction. Because of the concomitant use of drugs, drug interactions may have played a significant role in the elevated

digoxin levels.

Keywords: digoxin, intoxication, neuropsychiatric manifestations

Published: May 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Alušík Š, Paluch Z, Lejsková M, Jedličková V, Adámek T. Neuropsychiatric manifestations in digoxin intoxication. Klin Farmakol Farm. 2009;23(4):162-165.
Download citation

References

  1. McDonnell Cooke D. The use of central nervous system manifestations in the early detection of digitalis toxicity. Heart Lung 1993; 22: 477-481. Go to original source...
  2. Abas-Santos F, Carcas JA, Ibanez C, Frías J. Digoxin level and clinical manifestations as determinants in the diagnosis of digoxin toxicity. Therapeut Drug Monit. 2000; 22: 163-168. Go to original source... Go to PubMed...
  3. Marik PE, Fromm L. A case series of hospitalized patients with elevated digoxin levels. Am J Med 1998; 105: 110-115. Go to original source... Go to PubMed...
  4. Williamson KM, Trasher KA, Fulton KB, et al. Digoxin toxicity. An evaluation in current clinical practice. Arch Intern Med 1998; 158: 2444-2449. Go to original source... Go to PubMed...
  5. Lely AH, van Enter CH. Non-cardiac symptoms of digitalis intoxication. Am Heart J 1972; 83: 149-152. Go to original source... Go to PubMed...
  6. Lely AH, Van Enter CHJ. Large-scale Digitoxin Intoxication. Br Med J 1970; 3: 737-740. Go to original source... Go to PubMed...
  7. Rentsch D, Dumont P, Borgacci S, Carballeira Y, Detonnac N, Archinard M, Andreoli Prevalence and treatment of depression in a hospital department of internal medicine. Gen Hosp Psychiatr 2007; 29: 25-31. Go to original source... Go to PubMed...
  8. Sagel J, Matissonn R. Neuropsychiatric Disturbance as the Manifestation of Digitalis Toxicity. S Afr Med J 1972; 46: 512-514.
  9. Song YH, Terao T, Shiraishi Y, Nakamura J. Digitalis Intoxication Misdiagnosed as Depression- Revisited. Psychosomatics 2001; 42: 369-370. Go to original source... Go to PubMed...
  10. El-Mallakh RS, Hedges S, Casey D. Digoxin encephalopathy presenting as mood disturbance. J Clin Psychopharmacol 1995; 15: 82-83. Go to original source... Go to PubMed...
  11. Leibovitz A, Rosin L, Gil I, Berant A, Habot B. Digoxin Intoxication in Patients of a Geriatric Hospital: A Second Look 10 Years After. J Aging Pharmacother 2003; 13: 29-35. Go to original source...
  12. Butler VP jr, Odel JG, Rath E, et al. Digitalis Induced Visual Disturbances with Therapeutic Serum Digitalis Concentrations. Ann Intern Med 1995; 123: 676-680. Go to original source... Go to PubMed...
  13. Greenaway JR, Abuaisha B, Bramble MG. Digoxin toxicity presenting as encephalopathy. Postgrad Med J 1996; 72: 367-368. Go to original source... Go to PubMed...
  14. Steimer W, Muller C, Eber B. Digoxin Assays: Frequent, Substantial, and Potentially Dangerous Interference by Spironolactone, Canrenone, and Other Steroids. Clin Chem 2002; 48: 507-516. Go to original source...
  15. Horn JH, Hansten PD. Drug interactions with Digoxin: The role of P-glycoprotein. http://www.pharmacytimes.com/issue/pharmacy/2004/2004-10/2004-10-4618.
  16. Fromm MF, Kim RB, Stein CM, Wilkinson GR, Roden DM. Inhibition of P-Glycoprotein-Mediated Drug Transport. A Unifying mechanism to explain the interaction between digoxin and quinidine. Circulation 99: 1999: 552-557. Go to original source... Go to PubMed...
  17. Englund G, Hallberg P, Artursson P, Michaelsson K, Melhus H. Association between the number of coadministered P-glycoprotein inhibitors and serum levels in patients on therapeutic drug monitoring. BMC Med 2004; 2: 8. Go to original source... Go to PubMed...




Clinical Pharmacology and Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.